On this page
MERRF
MERRF is a rare genetic condition that typically manifests in childhood or adolescence, causing symptoms such as muscle jerks (myoclonic epilepsy), uncoordinated movements (ataxia), and muscle weakness. It affects multiple body systems due to problems with energy production in the cells.
Overview
MERRF, short for Myoclonic Epilepsy with Ragged Red Fibres, is a rare and progressive condition. It belongs to a group of disorders known as mitochondrial diseases, which occur when mitochondria - the 'powerhouses' within our cells - do not function correctly. This leads to a lack of energy, particularly in tissues with high energy demands like the brain and muscles [PMID:16145391]. The condition typically presents with a range of neurological symptoms, often starting in childhood or early adulthood.
Symptoms & clinical features
The symptoms of MERRF can vary significantly between individuals, even within the same family. Key features often include myoclonic epilepsy, which involves sudden, involuntary muscle jerks that can be difficult to control. Another common symptom is ataxia, leading to problems with balance and coordination. Muscle weakness (myopathy) is also typical, contributing to difficulties with movement and daily activities [PMID:20301386].
Other potential symptoms include hearing loss, optic atrophy (degeneration of the nerves that carry visual information from the eyes to the brain), and short stature. Some individuals may experience peripheral neuropathy, affecting nerves outside the brain and spinal cord, leading to numbness or weakness. Heart problems (cardiomyopathy) can also occur, and in some cases, individuals may develop lipomas (benign fatty tumours) [PMID:16145391]. The progressive nature of MERRF means that symptoms often worsen over time.
Video: Genetics 101
Affected organs
MERRF primarily affects organs and tissues that require a significant amount of energy. The brain is profoundly impacted, leading to the neurological features such as epilepsy and ataxia. Muscles are also significantly affected, causing weakness and contributing to the 'ragged red fibres' seen in muscle biopsies - a distinctive finding indicating abnormal mitochondria within muscle cells. Other organs that can be affected include the ears (leading to hearing loss), eyes (optic atrophy), and the heart (cardiomyopathy).
Risks & severity
MERRF is a progressive disorder, meaning symptoms generally worsen over time. The severity and rate of progression can vary widely among individuals. While symptoms often begin in childhood or adolescence, they can sometimes appear later in life. The condition is rare, and its exact prevalence is not well established. The clinical course can be highly unpredictable, ranging from relatively mild to severe, significantly impacting quality of life and lifespan. Regular monitoring and supportive care are crucial for managing symptoms and complications.
Genetic causes
MERRF is a mitochondrial disorder, meaning it is caused by genetic changes within mitochondrial DNA (mtDNA) rather than nuclear DNA. The most common cause, found in approximately 80-90% of individuals with MERRF, is a specific change in the MT-TK gene [PMID:20301386]. This gene provides instructions for making a transfer RNA (tRNA) molecule involved in protein synthesis within the mitochondria. Other, less common genetic changes in different mitochondrial genes can also cause MERRF. These changes impair the mitochondria's ability to produce energy efficiently, particularly for cells that need a lot of power, like those in the brain and muscles. This energy deficit leads to the diverse symptoms observed in MERRF.
Inheritance pattern
MERRF has a mitochondrial inheritance pattern. This means the genetic changes causing the condition are located in the mitochondrial DNA, which is inherited exclusively from the mother. All children of a mother with MERRF are at risk of inheriting the genetic change. However, the severity of the condition can vary greatly, even among family members who have inherited the same genetic change. This is due to a phenomenon called heteroplasmy, where a cell can contain a mixture of healthy and mutated mitochondrial DNA. The proportion of mutated mtDNA can differ between cells, tissues, and even between individuals in the same family, influencing symptom presentation and severity.
Diagnosis & testing
Diagnosing MERRF typically involves a combination of clinical assessment, neurological examination, and specialised tests. Clinical features such as myoclonic epilepsy, ataxia, and muscle weakness may raise suspicion. Further investigations often include a muscle biopsy, which can reveal 'ragged red fibres' under a microscope, indicative of mitochondrial dysfunction. Blood tests might show elevated lactate levels, suggesting impaired energy metabolism.
Genetic testing is crucial for confirming a diagnosis of MERRF and identifying the specific genetic change in mitochondrial DNA. This testing is usually performed by specialist NHS laboratories. A referral to a clinical genetics service by a GP or specialist is the typical route for accessing genetic testing. The NHS Genomic Medicine Service offers genomic testing for mitochondrial disorders, often under specific R-codes, such as R86 for 'Mitochondrial disorders - nuclear genes', although MERRF is primarily linked to mitochondrial DNA changes.
Management & lifestyle
While there is currently no cure for MERRF, management focuses on alleviating symptoms and improving quality of life. Treatment is supportive and multidisciplinary, involving various specialists such as neurologists, cardiologists, audiologists, and physiotherapists. Anti-epileptic medications may be used to control seizures, and physical therapy can help maintain muscle function and improve coordination.
Regular monitoring for potential complications, such as heart problems, hearing loss, and vision changes, is important. Some individuals may be advised to take certain vitamin supplements, though their efficacy for MERRF is not universally established. It is vital for individuals with MERRF to avoid certain medications that could worsen mitochondrial function. All management decisions should be made in consultation with a healthcare team following NHS guidelines and pathways. Genetic counsellors play a key role in providing information and support to affected individuals and their families.
UK care pathway
In the UK, individuals suspected of having a mitochondrial disorder like MERRF would typically be referred to a specialist clinical genetics service within the NHS. Genetic counselling is an integral part of this pathway, offering information about the condition, inheritance patterns, and support. Genetic testing, often guided by NHS R-codes related to mitochondrial disorders, confirms the diagnosis. Ongoing care involves multidisciplinary teams at specialist centres, aligning with the NHS Genomic Medicine Service framework for rare diseases.
Frequently asked questions
What does 'Ragged Red Fibres' mean?
Ragged Red Fibres refer to an abnormal appearance of muscle cells when viewed under a microscope after a special stain is applied. They indicate a buildup of diseased mitochondria beneath the muscle cell membrane, a characteristic finding in some mitochondrial disorders like MERRF.
Is MERRF always inherited from the mother?
Yes, MERRF is caused by changes in mitochondrial DNA (mtDNA), which is exclusively passed down from the mother to all her children. Fathers do not pass on their mitochondrial DNA.
Can MERRF affect different people in the same family differently?
Yes, even within the same family, individuals who inherit the same genetic change for MERRF can experience very different symptoms and severity. This is due to 'heteroplasmy,' meaning the proportion of altered mitochondrial DNA can vary from person to person and even in different tissues within the same person.
Are there specific medications I should avoid if I have MERRF?
Individuals with MERRF should be cautious with certain medications that might interfere with mitochondrial function. It is essential to discuss all medications, including over-the-counter drugs and supplements, with your healthcare team to ensure they are safe and appropriate for you.
Is there a cure for MERRF?
Currently, there is no cure for MERRF. However, treatments focus on managing symptoms, preventing complications, and improving the quality of life through a combination of medication, therapies, and supportive care provided by a multidisciplinary team of specialists.